Ikerian

We are happy to share the news that our portfolio company Ikerian (formerly Retinai), a leading developer of software solutions for medical image and data management, and AI in healthcare, has completed a first-close of a USD 8M Series B funding led by Sanoptis and existing co-investors including THINC Ventures, Zürcher Kantonalbank, and Verve Ventures. The partnership with Sanoptis will help Ikerian bring cutting-edge AI solutions to over hundreds of clinics across Europe, enhancing patient care and data workflows in the clinic. 💪 💪 Congrats to Carlos Ciller, Stefanos Apostolopoulos, Sandro De Zanet and team on this important milestone! 🔎 🔎 Read more about the news here ➡️ ➡️ https://lnkd.in/eRDKUCX9 cc Christian Schütz Matterwave Ventures

Are you a fluent German speaker ready to make a difference in the healthcare technology space? We're thrilled to announce 2 new full-time remote positions open! 1️⃣ 𝐂𝐨𝐦𝐦𝐞𝐫𝐜𝐢𝐚𝐥 𝐎𝐩𝐞𝐫𝐚𝐭𝐢𝐨𝐧𝐬 𝐆𝐞𝐧𝐞𝐫𝐚𝐥𝐢𝐬𝐭  Help enhance customer experiences by analyzing needs, supporting onboarding processes, and improving cross-functional integration. Your passion for customer satisfaction and operational efficiency could be the key to driving success 👉 https://lnkd.in/exaju_ms 2️⃣ 𝐂𝐮𝐬𝐭𝐨𝐦𝐞𝐫 𝐒𝐮𝐩𝐩𝐨𝐫𝐭 𝐑𝐞𝐩𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐯𝐞  Do you thrive in problem-solving and communication? As the primary point of contact for our customers, you’ll manage support tickets, assist users with new features, and ensure smooth operations across teams. Your customer-centric approach is what we need! 👉 https://lnkd.in/ewd53Vgb If you're passionate about healthcare innovation and fluent in German, we want to hear from you! Check out the job descriptions and submit your application today. Let's shape the future of healthcare together!

We are thrilled to announce the first close of our USD 8M (CHF 6.73M) Series B funding led by Sanoptis, with continued support from existing investors including THINC Ventures (Topcon Healthcare Inc.), Zürcher Kantonalbank, and Verve Ventures. This funding will accelerate the development and commercialization of 𝐑𝐞𝐭𝐢𝐧𝐀𝐈 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲®️ and 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲 𝐂𝐎𝐍𝐍𝐄𝐂𝐓™️, enabling seamless data connectivity and AI-driven insights in ophthalmology, optometry and beyond. Through our partnership with Sanoptis, we are bringing cutting-edge AI solutions to hundreds of clinics across Europe, enhancing patient care and data workflows in the clinic. Our journey doesn’t stop here! Through Ikerian we are expanding our capabilities into new therapeutic areas, including neurodegenerative disorders and rare diseases, leveraging real-world evidence (RWE) and AI to support better decision-making in healthcare. A big thank you to our partners, investors, and the incredible Ikerian / Retinai team for making this milestone possible! Learn more 👉 https://lnkd.in/ei8x7-w6 💡 Stay tuned for more updates as we continue to revolutionize healthcare through data and AI💡 #SeriesB #HealthTech #AIinHealthcare #Ophthalmology #DataDriven #HealthcareInnovation #eyecare #machinelearning #artificialintelligence #innovation

✨ The hunt for brilliant minds continues at the EPFL Forum! 🧠✨ Our team is out in full force, connecting with the best and brightest in Data Science and Machine Learning! A huge thanks to Renske van der Vlugt and Alicja Krzeminska-Sciga for representing Ikerian AG. If you're at the event, come by our booth #F15 to see how we’re shaping the future of tech! 💡 And if you’re not attending but want to join our team, check out our open positions here: https://lnkd.in/dty2C3k #EPFLForum #Recruitment #DataScience #MachineLearning #Innovation

We're excited to announce that we will be at BioTechX in Basel, Switzerland, from October 9-10, 2024! Our CEO Carlos Ciller and CSO Sandro De Zanet will be representing us at this important event. We are looking forward to connecting with fellow researchers and innovators in the biotech space. At Ikerian, we are passionate about empowering researchers with cutting-edge AI tools for ophthalmology, and beyond! If you're interested in learning how our advanced imaging analysis solutions can accelerate your research, come chat with us at BiotechX! See you there! #BiotechX2024 #AIinHealthcare #RetinalResearch #Ophthalmology #Ikerian

We're excited to introduce Jonathan Sourris, our new Business Developer in Sales, and Wojciech Tarnawski, our new Project Manager for Clinical Trials in the Research department! Jonathan brings his expertise in Life Sciences software sales, while Wojtek has over 20 years of experience in Med-Tech and Life Science industries. Some of the team celebrated their arrival with drinks—cheers to new adventures together! 🍻 Let’s give them a warm welcome as they embark on this journey with us! #TeamGrowth #Welcome #NewBeginnings

Ever wondered about the origin of Ikerian or what cutting-edge innovation drives our mission forward? Curious about #Oculomics and the transformative potential behind it for systemic and chronic diseases? Our CEO, Carlos Ciller, dives deep into these topics and more in an insightful conversation with Amazon Web Services (AWS) on their latest podcast. 🎙️ This is your chance to learn about the future of healthcare through #AI and how we’re using technology to reshape the way we understand and diagnose diseases. We explore how #Ikerian empowers stakeholders to: 🔎 Detect diseases sooner through novel biomarkers 📈 Optimize treatment plans with curated data insights 🤝 Expedite clinical collaboration with efficient workflows ️⚡️ Accelerate drug development 🔈Listen on the Health Podcast Network, or wherever you listen to your podcasts: https://lnkd.in/gymfvD6C #AWSHealthPod #HealthcarePodcasts #Biomarkers #MedTech #startup #innovation #eyecare #startup #artificialintelligence #machinelearning #medicalimaging

Are you ready to take your career to the next level? We are thrilled to announce 3 exciting job opportunities to join us! Explore our open positions: 1️⃣ 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐞𝐫 (𝐑𝐞𝐦𝐨𝐭𝐞 𝐄𝐮𝐫𝐨𝐩𝐞)  Are you a strategic thinker with a passion for healthcare technology? We are looking for someone to drive new business opportunities in Ophthalmology Pharma, Biotech, and CROs. If you have experience in complex health tech environments and a consultative sales approach, we want you 👉 https://lnkd.in/eXS-eDs4 2️⃣ 𝐂𝐮𝐬𝐭𝐨𝐦𝐞𝐫 𝐒𝐮𝐜𝐜𝐞𝐬𝐬 𝐌𝐚𝐧𝐚𝐠𝐞𝐫 𝐒𝐨𝐟𝐭𝐰𝐚𝐫𝐞 Ensure our clients derive maximum value from our cloud-based data management platform. If you have a passion for customer satisfaction, problem-solving, and healthcare innovation, this is the perfect role for you 👉https://lnkd.in/eEf5cWbv 3️⃣ 𝐏𝐫𝐨𝐝𝐮𝐜𝐭-𝐄𝐧𝐚𝐛𝐥𝐞𝐝 𝐒𝐚𝐥𝐞𝐬 𝐌𝐚𝐧𝐚𝐠𝐞𝐫 (𝐑𝐞𝐦𝐨𝐭𝐞 𝐄𝐮𝐫𝐨𝐩𝐞)  Join our customer-centric team and ensure our clients have the best experience. If you excel at building relationships and solving client issues, this role is for you 👉 https://lnkd.in/ewsNPRPX Ready to embark on a new adventure with us? Check out the detailed job descriptions and submit your application. We can't wait to see what you bring to our team! #CareerOpportunity #JoinOurTeam #JobOffers #Hiring #CareerGrowth #TechJobs #MarketingJobs #CustomerSuccessJobs

How are retinal biomarkers transforming the early detection of neurodegenerative diseases like Alzheimer's and Parkinson's? Retinal imaging, specifically OCTs, can reveal subtle yet vital changes indicative of early stages of diseases like MS, Alzheimer’s, and Parkinson's. With our AI-powered platform, Discovery, we can identify these minute alterations, supporting earlier diagnostics and potentially improving treatment outcomes. Explore our blog to learn more about this cutting-edge approach to neurology through ophthalmology 👉 https://lnkd.in/eTbtYVaq #Innovation #HealthTech #EyeHealth Retinai

Our first post! Today Ikerian is formally launched with the final close of our Series A Extension financing at $6.18M (CHF 5.65M), bringing to $11.66M (CHF 10.66M) the total equity raised to date! As part of the financing, and to facilitate our evolution and growth, RetinAI Medical AG is rebranded as Ikerian AG, with a wholly-owned subsidiary RetinAI U.S. Inc. (Retinai) focused on the ophthalmology market. Pleased to welcome new investor, the Corporate Venture Capital arm of Topcon Healthcare and Zürcher Kantonalbank (ZKB) and for the continued support to our existing Series A and seed investors the btoventures Industrial Technologies fund, managed by Matterwave Ventures, Verve Ventures and private investors. The new funds will support continued development and commercial roll out of RetinAI Discovery® in #ophthalmology and #optometry and for Ikerian's expansion into new therapeutic areas prioritizing neurodegenerative disorders, vascular conditions and rare diseases. Red the full press release here – https://lnkd.in/gxW54UEu #machinelearning #eyecare #healthcare #clinicalstudies #screening #prescreening #generativeAI #pharmaceuticalresearch #clinicaldevelopment #artificialintelligence #AI #startup #financing #seriesA #opthalmology #healthtech